Insider · CIK 0001789490

Fletcher Aaron G.L.

CIK 0001789490 Name as filed on the most recent filing

Filed as Fletcher Aaron G.L. (34)

129 transaction lines · from 34 filings · filed 2019-10-29 to 2025-06-30 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

22 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-26 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2022-08-26 P, Open-market purchase In8Bio, Inc.INAB 2,768, acquired Open Form 4 filing 0001104659-22-095951
2022-08-26 P, Open-market purchase In8Bio, Inc.INAB 2,625, acquired Open Form 4 filing 0001104659-22-095951
2022-08-17 P, Open-market purchase In8Bio, Inc.INAB 3 lines 96,500, acquired Open Form 4 filing 0001104659-22-092665
2022-08-16 P, Open-market purchase In8Bio, Inc.INAB 3 lines 3,370,000, acquired Open Form 4 filing 0001104659-22-092056
2022-05-24 P, Open-market purchase Cue Biopharma, Inc.CUE 183,700, acquired Open Form 4 filing 0001209191-22-031791
2022-05-23 P, Open-market purchase Cue Biopharma, Inc.CUE 528,000, acquired Open Form 4 filing 0001209191-22-031791
2022-05-17 P, Open-market purchase TFF Pharmaceuticals, Inc.TFFP 124,968, acquired Open Form 4 filing 0001213900-22-027797
2022-05-16 P, Open-market purchase TFF Pharmaceuticals, Inc.TFFP 413,100, acquired Open Form 4 filing 0001213900-22-027797
2022-04-04 P, Open-market purchase TFF Pharmaceuticals, Inc.TFFP 2 lines 3,504,380, acquired Open Form 4 filing 0001213900-22-017959
2022-03-31 P, Open-market purchase Cue Biopharma, Inc.CUE 3,498,600, acquired Open Form 4 filing 0001209191-22-022568
2021-10-13 S, Open-market sale Cognition Therapeutics IncCGTX 1,083, disposed Open Form 4 filing 0001104659-21-126905
2021-10-13 P, Open-market purchase Cognition Therapeutics IncCGTX 3 lines 2,280,000, acquired Open Form 4 filing 0001104659-21-126905
2020-11-24 P, Open-market purchase Cue Biopharma, Inc.CUE 82,776, acquired Open Form 4 filing 0000899243-20-032155
2020-11-24 P, Open-market purchase TFF Pharmaceuticals, Inc.TFFP 75,656, acquired Open Form 4 filing 0001213900-20-039036
2020-06-24 P, Open-market purchase Cue Biopharma, Inc.CUE 2 lines 186,572, acquired Open Form 4 filing 0001209191-20-038885
2020-05-26 P, Open-market purchase TFF Pharmaceuticals, Inc.TFFP 101,600, acquired Open Form 4 filing 0001213900-20-013471
2020-04-15 P, Open-market purchase TFF Pharmaceuticals, Inc.TFFP 26,342, acquired Open Form 4 filing 0001213900-20-009441
2020-04-06 P, Open-market purchase TFF Pharmaceuticals, Inc.TFFP 26,508, acquired Open Form 4 filing 0001213900-20-008707
2020-04-03 P, Open-market purchase TFF Pharmaceuticals, Inc.TFFP 66,490, acquired Open Form 4 filing 0001213900-20-008707
2020-04-02 P, Open-market purchase TFF Pharmaceuticals, Inc.TFFP 1,875, acquired Open Form 4 filing 0001213900-20-008707
2019-10-25 P, Open-market purchase TFF Pharmaceuticals, Inc.TFFP 10,000, acquired Open Form 4 filing 0001213900-19-021415

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 21
  • Open-market sale 1
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Fletcher Aaron G.L., insider transactions. Retrieved 2026-08-26 from https://ebomi.com/insider/0001789490

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.